| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034550 |
| Receipt No. | R000039386 |
| Scientific Title | Proportion of complete muscularis mucosae resection by cutting hot snare polypectomy: a randomized controlled trial |
| Date of disclosure of the study information | 2018/10/17 |
| Last modified on | 2022/10/21 (Ver. 4) |
| Basic information | ||
| Public title | Proportion of complete muscularis mucosae resection by cutting hot snare polypectomy: a randomized controlled trial | |
| Acronym | Proportion of complete muscularis mucosae resection by cutting hot snare polypectomy | |
| Scientific Title | Proportion of complete muscularis mucosae resection by cutting hot snare polypectomy: a randomized controlled trial | |
| Scientific Title:Acronym | Proportion of complete muscularis mucosae resection by cutting hot snare polypectomy | |
| Region |
|
|
| Condition | ||
| Condition | Colon polyp of endoscopic treatment adapttion | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Consideration of effectiveness for Hot Snare Polypectomy (Cutting HSP; C-HSP) using the incision wave |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The ratio of completely resected the muscularis mucosa just under the lesion by the pathological specimen |
| Key secondary outcomes | 1) Ratio of acknowledging CSDPs after resection
2) 3) 4) 5) Average time of hemostasis 6) Ratio of bleeding which was required intraoperative hemostasis just after of polypectomy 7) Incidence of uncontrolled intraoperative bleeding 8) Ratio of postoperative bleeding 9) Ratio of adverse event occurrence |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Hot Snare Polypectomy (C-HSP) | |
| Interventions/Control_2 | Cold snare polypectomy(CSP) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Persons whose age at agreement acquisition is between 20 and 80 years old.
2) Person who has a sessile or flat type lesion of 6 mm or more and less than 10 mm in the colonoscopy exam performed at our hospital in the past year. 3) Person who got document agreement by his/her free will after fully understanding after participating in this research. 4) People whose PS (ECOG) is either 0 or 1. 5) Clinical inspection test within 28 days of registration date, who satisfy all the conditions as below. Number of platelets >= 100,000/microL Serum creatinine value <= 2.0 mg/dL PT (%) >= 40% or more. 6) Person who can track the progress of 28 days after treatment. |
|||
| Key exclusion criteria | 1) Person who has registered history in this exam.
2) Persons diagnosed with inflammatory bowel disease, colon polyposis. 3) Lesions of 10 mm or more, lesions suspected of cancer, those who are known to have pedunculated and depressed lesions in advance. 4) Persons undergoing continuous systemic administration of steroids and antithrombotics. 5) Persons with blood coagulation function disorder. 6) During pregnancy Persons who are likely to become pregnant or who are lactating. 7) Persons who are merging psychosis or psychiatric symptoms and who seem to be difficult to participate in the exam. 8) Persons who have active bacterial and fungal infection complications (having a fever> 38.5 degrees and suggesting bacterial infection by imaging diagnosis or bacteriologic examination). 9) Persons who are merging uncontrolled high-blood pressure. 10) Persons who have respiratory diseases requiring sustained oxygen administration. 11) Persons who are in dialysis. 12) Others who judged that the doctor in charge is inappropriate as the research subject |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Southern Tohokou General Hospital
|
||||||
| Division name | Gastroenterology | ||||||
| Zip code | |||||||
| Address | Yatsuyamada 7-161, Koriyama, Fukushima | ||||||
| TEL | 024-934-5322 | ||||||
| ryota.koyanagi@mt.strins.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Japan Society of Clinical Research | ||||||
| Division name | Director | ||||||
| Zip code | |||||||
| Address | Osaka Ekimae 4th building 10F Umeda 1-11-4-1000, Kita-ku, Osaka | ||||||
| TEL | 06-6131-5495 | ||||||
| Homepage URL | |||||||
| tamaki@japanscr.org | |||||||
| Sponsor | |
| Institute | Southern Tohokou General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 総合南東北病院(福島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039386 |